
Australian scientists have developed a revolutionary weekly injection that could end the daily pill burden for 8.5 million people living with Parkinson's disease worldwide.
The innovative biodegradable gel delivers a controlled release of levodopa and carbidopa—the gold-standard therapy for Parkinson's disease.